EUVIMEDEUVIMED entdecken
Crossref

Physalin F Inhibits Cell Viability and Induces Apoptosis in Non-small Cell Lung Cancer Cells

Jhy-Ming Li, Kuo-Tai Yang, Chean-Ping Wu

Anticancer Research · 2025

DOI: 10.21873/anticanres.17668 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2025. Verfasst von Jhy-Ming Li und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Animal Science, National Chiayi University, Chiayi City, Taiwan, R.O.C. jml@mail.ncyu.edu.tw. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Apoptosis, Lung Neoplasms, Secosteroids.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND/AIM: Lung cancer has a high morbidity rate and remains the leading cause of mortality worldwide. Most patients with non-small cell lung cancer (NSCLC) are diagnosed at advanced stages, rendering surgical resection unfeasible and prognosis poor. Therefore, effective therapeutic agents for NSCLC are urgently needed. Physalin F, a steroid derivative isolated from Physalis angulata L., reduces cancer cell viability through unclear mechanisms. This study investigated the molecular mechanisms and therapeutic potential of physalin F in NSCLC cells in vitro. MATERIALS AND METHODS: Four NSCLC cell lines, harboring either wild-type (H460 and A549) or mutant (H1650 and H1975) EGFR, were treated with various concentrations of physalin F. Cell viability was assessed using the CCK-8 reagent. Apoptosis and cell-cycle progression were analyzed via flow cytometry and western blotting. RESULTS: Physalin F significantly inhibited cell viability and induced apoptosis through the intrinsic and extrinsic pathways in NSCLC cells. It caused G2/M-phase cell cycle arrest. Mechanistically, physalin F down-regulated AKT and MAPK signaling pathways. Conversely, enforced AKT expression reversed physalin F-induced suppression of cell viability in NSCLC cells. CONCLUSION: Physalin F suppresses NSCLC cell growth via PI3K/AKT and RAS/MAPK signaling pathways. These findings suggest that physalin F holds potential as an effective therapeutic agent for NSCLC harboring both wild-type and mutant EGFR.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungApoptosisLung NeoplasmsSecosteroidsHumansCell SurvivalCell Line, TumorCell ProliferationProto-Oncogene Proteins c-aktSignal TransductionErbB ReceptorsA549 Cells

Stichwörter der Autor:innen

AKT/MAPK signaling pathwayEGFRPhysalin FPhysalis angulata Lnon-small cell lung cancer

Substanzen

SecosteroidsProto-Oncogene Proteins c-aktErbB Receptors

Autor:innen und Institutionen

  • Department of Animal Science, National Chiayi University, Chiayi City, Taiwan, R.O.C. jml@mail.ncyu.edu.tw.
  • Department of Animal Science, National Pingtung University of Science and Technology, Pingtung, Taiwan, R.O.C.
  • Department of Animal Science, National Chiayi University, Chiayi City, Taiwan, R.O.C. wcp@mail.ncyu.edu.tw.

Zitieren

APA

Li, J. M., Yang, K. T., & Wu, C. P. (2025). Physalin F Inhibits Cell Viability and Induces Apoptosis in Non-small Cell Lung Cancer Cells. Anticancer Research. https://doi.org/10.21873/anticanres.17668

Vancouver

Li JM, Yang KT, Wu CP. Physalin F Inhibits Cell Viability and Induces Apoptosis in Non-small Cell Lung Cancer Cells. Anticancer Research. 2025. doi:10.21873/anticanres.17668

BibTeX
@article{Li2025,
  author = {Li, Jhy-Ming and Yang, Kuo-Tai and Wu, Chean-Ping},
  title = {Physalin F Inhibits Cell Viability and Induces Apoptosis in Non-small Cell Lung Cancer Cells},
  journal = {Anticancer Research},
  year = {2025},
  doi = {10.21873/anticanres.17668}
}
Kostenlos starten →